MML backed Luneau Technology makes a strategic investment in Chinese partner Ming Sing Optical

Luneau Technology Group (Luneau Tech), one of the global leading players in the optical medical equipment market (optometric and edging products) has finalised a strategic investment in Chinese partner Ming Sing Optical (MSOC).

MSOC is a Chinese based (Shanghai region) manufacturer and distributor of optometry equipment.

Both companies had already established a working partnership with successful manufacturing and distribution agreements in the Chinese market prior to this investment.

Luneau’s investment strengthens this partnership and will allow Luneau to further expand its geographical footprint in Asia with new manufacturing, sourcing capacities and access to local market whilst Ming Sing further expands the development of its portfolio of products within Luneau group.

After the acquisition of AIT in the U.S. and of Haag Streit’s French assets, this is Luneau’s 3rd selective external growth development since MML’s investment in early 2015.

Henry-Louis Mérieux, Managing Partner at MML comments:

“After several years of strong growth in Europe and America in particular, this partnership between two groups that know each other very well is a new milestone in Luneau’s global growth strategy, supporting its development in the strategically important Asian market with the joint fruitful enhancement of this partnership with Ming Sing”.

En savoir plus sur
Partagez cette histoire
Nouvelles connexes
Transformation of Luneau Technology delivers MML a return of 2.1x
MML backed Luneau acquires the French assets of Haag Streit
A new step for Luneau Technology

MML investor portal logins

For investors in MML Fund VI, MML Ireland I & MML Ireland II

For investors in MML Fund VII

Connexions au portail des investisseurs MML

Pour les investisseurs aux MML Fund VI, MML Irland I et MML Ireland II

Pour les investisseurs au MML Fund VII